Sermorelin / GHRP-6 Blend is a research peptide formulation combining two well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Sermorelin and Growth Hormone–Releasing Peptide-6 (GHRP-6). Sermorelin is a synthetic analog of growth hormone–releasing hormone (GHRH), while GHRP-6 is a growth hormone secretagogue receptor (GHS-R) agonist originally developed as a hexapeptide. Together, this blend is formulated for laboratory research focused on pulsatile growth hormone release, receptor signaling pathways, and coordinated endocrine response mechanisms.
Prior to the targeted synthesis and study of these peptides, research into growth hormone modulation relied largely on less selective secretagogues and broader hormonal interventions. In controlled research settings, Sermorelin has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a relatively short duration of activity. GHRP-6 has been widely researched for its role in ghrelin receptor activation and its influence on growth hormone secretion amplitude and frequency. The combination allows researchers to examine complementary mechanisms involved in growth hormone pulsatility, secretion dynamics, and endocrine signaling coordination.
Currently, the Sermorelin / GHRP-6 Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic signaling, appetite-related hormone interactions, and circadian growth hormone release patterns. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
The Sermorelin, GHRP-6 (5mg / 5mg) Blend is developed for laboratory research examining growth hormone axis signaling, hypothalamic–pituitary communication, and endocrine biomarker behavior in controlled experimental models. By combining a growth hormone–releasing hormone analog with a growth hormone secretagogue, researchers can study how complementary signaling pathways influence pulsatile growth hormone release and related endocrine responses.
Multi-peptide research models are commonly used in endocrine and metabolic research to evaluate how upstream hypothalamic signals interact with pituitary hormone release mechanisms. In structured laboratory environments, these protocols may help investigators analyze hormone pulse behavior, pathway signaling interactions, and biomarker fluctuations associated with GH-axis activity.
Sermorelin, GHRP-6 (5mg / 5mg) Blend – Research Specifications:
| Format | Lyophilized peptide blend (research format) |
| Contents | Sermorelin (5mg) + GHRP-6 (5mg) |
| Purity / Identity | Research-grade; refer to Certificate of Analysis (COA) for lot-specific analytical data |
| Source | Peptide synthesis with standardized processing and QC documentation |
| Appearance | Powder (lyophilized) |
| Storage Conditions | Store sealed in a cool, dry environment protected from heat, light, and moisture. Maintain lot integrity per laboratory SOPs. |
| Research Use Only | Supplied exclusively for laboratory research use. Not for human consumption, clinical use, or veterinary applications. |
Sermorelin is a synthetic analog of growth hormone–releasing hormone (GHRH) frequently studied in research examining hypothalamic–pituitary axis signaling. In experimental models, investigators may evaluate how Sermorelin influences growth hormone pulse timing and endocrine communication within regulatory hormone pathways.
GHRP-6 is a growth hormone secretagogue studied for its interaction with ghrelin receptor pathways involved in pituitary hormone signaling. In laboratory settings, this peptide is commonly used in research models exploring hormone release dynamics and endocrine biomarker responses associated with GH-axis activity.
When Sermorelin and GHRP-6 are combined within a research protocol, investigators may analyze how GHRH pathway activation interacts with ghrelin receptor signaling. These studies often measure hormone pulse frequency, amplitude, and downstream biomarker responses to understand how endocrine signaling pathways interact in multi-variable research models.
Researchers studying these peptides individually may reference the product pages for Sermorelin and GHRP-6.
Important Research Notice: Nordsci products are supported by lot-level analytical documentation. Certificates of Analysis are available to support internal audits, method alignment, and reproducibility across research studies.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR CONDITION.
A primary research objective for this peptide combination is evaluating pulsatile growth hormone release patterns. Researchers may monitor endocrine marker changes across defined sampling intervals to observe how multiple signaling pathways influence hormone signaling dynamics.
Because Sermorelin stimulates upstream GHRH pathways while GHRP-6 activates ghrelin receptor signaling, this blend provides a useful experimental model for studying communication between hypothalamic signals and pituitary hormone responses.
GH-axis studies frequently include downstream biomarker measurements. Researchers may analyze endocrine marker fluctuations associated with hormone signaling changes triggered by peptide pathway activation within controlled laboratory conditions.
Many experimental frameworks compare peptide blends with single-compound protocols. This allows investigators to determine whether observed signaling responses are driven by individual peptides or by the interaction of multiple endocrine signaling pathways.
The Sermorelin, GHRP-6 Blend should be handled according to standard peptide laboratory procedures emphasizing contamination prevention, appropriate storage conditions, and detailed experimental documentation. Maintaining stable laboratory environments helps support reproducible research results.
Protocol Design Considerations: Growth hormone signaling research is sensitive to circadian rhythm timing, metabolic baseline status, environmental variables, and experimental stress conditions. Standardized sampling windows and carefully controlled laboratory environments are essential for reliable data interpretation.
Note: The information above is provided solely as a research reference summary. All experimental work must be conducted by qualified researchers in appropriate laboratory facilities.
Each lot of this peptide blend includes a Certificate of Analysis verifying peptide identity and quality parameters. These analytical reports support procurement verification, regulatory documentation, and reproducibility tracking across research studies.
Laboratories sourcing peptides for endocrine signaling research typically prioritize traceable documentation, consistent synthesis standards, and reliable quality-control processes. Nordsci Peptides provides research-grade peptide materials supported by analytical documentation and manufacturing standards designed to support reproducible laboratory research.
IMPORTANT: This product is supplied exclusively for laboratory research use. It is not approved for human consumption or clinical application. Researchers are responsible for ensuring compliance with all applicable regulatory and institutional guidelines.
